[Mitai-announce] FW: Harvard Neglected Disease Conference - Co-Sponsorship

[maryxu (MIT)]

MISSING MEDICINES: Harvard's Response to the Challenge of Global Neglected
Diseases

 

Building on "Missing Medicines: Making University Drugs Accessible to the
Global Poor", an event last year on university licensing featuring Dr. Jim
Kim, this half-day conference will evaluate the role of Harvard University
in the global response to neglected diseases. Speakers include:

Dr. Steven Hyman, Provost of Harvard University, Former Director of the
National Institute of Mental Health; Professor Jon Clardy, Professor of
Biochemistry and Molecular Pharmacology, Harvard Medical School; Professor
Bruce Walker, Professor of Medicine at Harvard Medical School, Director of
the Partners AIDS Research Center at Massachusetts General Hospital; Dr.
Rebecca Weintraub - Instructor in Medicine at Harvard Medical School,
Executive Director of the Global Health Delivery Initiative; Professor Dyann
Wirth, Chair of Immunology and Infectious Diseases, Harvard School of Public
Health, Director of Harvard Malaria Initiative

Location: Tsai Auditorium, 
Center for Government and International Studies (CGIS), North Building
Saturday, April 12th
10:00am - 2:00pm
With a Student Opportunities Reception & Luncheon from 1:00-2:00pm

 

.    Less than ten percent of the world's research budget goes to diseases
that affect ninety percent of the world's population because they do not
constitute a market attractive to   private-sector R&D investment.
.    Even though universities such as Harvard are responsible for over half
of the basic science research conducted in the US, seldom is this research
applicable or available to the global poor.
.    Universities can take concrete steps to increase the amount of medical
technology research, development, and implementation relevant to global
neglected diseases, which could save millions of lives annually and help
eliminate this debilitating threat to development. 

 

Cosponsored by the Harvard College Global Health and AIDS Coalition and the
Harvard Institute for Global Health